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227-236This article provides data on the validity of the Xhosa versions of the Beck Depression Inventory-II (XBDI-II), the Beck
Hopelessness Scale (XBHS) and the Beck Anxiety Inventory (XBAI) based on a sample of 122 Xhosa respondents which
included students and patients. For patients, clinicians completed rating scales of Depression and Anxiety symptoms.
In tests of concurrent validity, depressed patients had significantly higher scores on the XBDI-II and XBHS than
students or patients who were not depressed. Similarly anxious patients had higher scores on the XBAI than students
and patients who were not anxious. Correlations with clinicians’ ratings were: .91 for XBDI-II scores and depression
ratings, and .88 for XBAI scores and anxiety ratings. Correlations between the three translated scales were similar to
those for the original scales. These analyses provide evidence that the translated scales have levels of concurrent and
convergent validity comparable to the originals.
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This is the third article in a series documenting the results
of a study in which Xhosa translations were made of the Beck
Depression Inventory-II, a 21-item self report scale that mea-
sures clinical symptoms of depression (BDI-II; Beck, Steer, &
Brown, 1996), the Beck Anxiety Inventory, a 21-item self re-
port scale that measures clinical symptoms of anxiety (BAI;
Beck & Steer, 1993), and the Beck Hopelessness Scale, a
20-item self report scale that measures clinical symptoms of
hopelessness (BHS; Beck & Steer, 1988).
Development of the BDI-II, BAI and BHS
The BDI-II has a long history as it is a revision of the BDI,
originally developed over forty years ago (Beck, Ward,
Mendelson, Mock, & Erbaugh, 1961). Since that time the BDI
or revisions of it have been widely used in clinical contexts
and in research. The original BDI was itself revised in 1972.
All items were given a four option format (some items had
more options in the original), alternative wording for the same
symptoms was eliminated as well as double negatives in the
phrasing of items (Beck, Rush, Shaw, & Emery, 1979). It was
formally published in 1979 and became known as the Beck
Depression Inventory-IA (BDI-IA). A further revision, the
BDI-II was made to align the symptoms with the diagnostic
criteria of the DSM-IV (American Psychiatric Association,
1994) and to more effectively tap the kind of severe depres-
sion that might warrant hospitalization (Beck et al., 1996).
The BHS also has a long history. Following clinical obser-
vations suggesting that hopelessness was a stronger predic-
tor of suicide attempts than depression alone, the BHS was
developed in 1974 (Beck, Weissman, Lester, & Trexler, 1974)
and was used in a series of studies on the relationship be-
tween hopelessness and suicide which confirmed the value of
using hopelessness as measured by the BHS as a predictor
of risk (Beck, & Steer, 1988, 1989; Beck, Brown, & Steer,
1989; Steer, Kumar, & Beck, 1993). It can therefore be used
in clinical settings where there is concern about particular patients
with respect to suicide risk.
The development of the BAI is more recent (Beck, Epstein,
Brown, & Steer, 1988; Beck & Steer, 1993). However it too is the
result of several decades of research. Anxiety symptom check-
lists in use before the BAI was developed tended to have rather
high correlations with measures of depression. This was in part
due to co-morbidity, but this natural correlation was enhanced by
having items of similar content in measures of anxiety and de-
pression. The BAI was specifically designed to reduce this, and to
provide a measure of clinical anxiety which was as pure as possi-
ble and distinct from depression.
Development and evaluation of the XBDI-II, XBAI and XBHS
Since its publication the BAI has also been widely used clini-
cally as well as in research. In the first article in the series, Steele
and Edwards (2008a) documented the process of translating
these scales into Xhosa. Xhosa is one of the Nguni group of Afri-
can languages (which also includes Zulu, Swazi and Ndebele)
and is the most widely used language among the Africans of the
Eastern Cape Province of South Africa. However it is also widely
spoken in the Western Cape and Gauteng. Steele and Edwards
reported and discussed a range of problems that were encoun-
tered, first in working with translators, and second, in finding
translations with appropriate equivalence to the original English.
They described the strategies used to resolve them, and provided
examples of the kinds of options for translating particular items
that were considered. The outcome of the translation process was
the Xhosa versions of these Beck scales: the XBDI-II, a transla-
tion of the BDI-II, the XBHS, a translation of the BHS, and the
XBAI, a translation of the BAI.
The second article (Steele & Edwards, 2008b) presented data
on the item analyses and internal consistency of the translated
scales. The results were encouraging as test-item correlations
and indices of internal consistency compared favourably with
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those obtained in research on the validation of the original Eng-
lish versions carried out in the USA.
This third article presents analyses designed to provide pre-
liminary evidence for the validity of the translated scales. The
first strategy employed was to compare different groups of re-
spondents selected because of predetermined clinical features.
The second was to examine the inter-correlations between the
three translated scales as these have implications for conver-
gent and discriminant validity.
Method
Participants: Participants were black first language
Xhosa-speaking people from the Eastern Cape of South Africa.
Five groups of participants were obtained to provide a basis for
establishing the validity of the scales.
Group 1 (Clinical Pilot): Respondents in this group were 22
patients (9 males and 13 females) recruited by three Clinical
Psychologists in private practice in Port Elizabeth, and two Clin-
ical Psychology interns at Fort England psychiatric hospital in
Grahamstown. They identified patients with whom they were
working who were available to complete the set of instruments.
These were the first respondents to complete the question-
naires once the definitive versions had been finalized (as de-
scribed by Steele & Edwards, 2008 a). The aim was to adminis-
ter the scales to a range of patients of different ages, presenting
problems and symptom severity in order to ensure that they
were understandable and usable in a routine clinical setting. Af-
ter each practitioner had administered four or more of the sets
of inventories, the second author met with him/her and con-
ducted a semi-structured interview which focused on the ease
of use of the inventories, whether there were any problematic
items, and whether respondents understood the language
used. As a result of these trials, no further changes were made
to the translations, and this paved the way for the collection of
the remaining data from a further four groups, as described be-
low. The mean age of this sample was 38.95 (SD = 11.43).
Group 2 (Student): This was a convenience sample consist-
ing of 26 Xhosa-speaking students from Rhodes University stu-
dents (10 males and 16 females). The researcher addressed an
undergraduate psychology class, explained the nature of the
project, and invited black Xhosa-speaking students to partici-
pate. Volunteers completed the scales during one of their after-
noon practical sessions under the supervision of a research as-
sistant. Students were assured of anonymity with respect to
any publications. They were given the option of writing their
names and contact details on the forms if they wanted feedback
on their results. They were further assured that only the re-
searcher would have access to the results and that no informa-
tion would be conveyed to any university officials. The mean
age of this group was 20.58 (SD = 5.72).
The last three groups were patients who were recruited in a
similar manner to the Clinical Pilot sample as described above.
The same Clinical Psychologists and interns took part and they
were supplemented by another Clinical Psychologist, a Xhosa
woman from East London, and three medical doctors who
worked at the same psychiatric hospital as the interns. These
were all practitioners familiar with the DSM-IV system who used
it in their everyday practice. A few practitioners were ap-
proached who did not use the DSM system and these were not
invited to participate in the study. These practitioners were
asked to make a clinical judgement as to whether each patient
was significantly depressed or anxious and to rate the degree of
each on a rating scale (described in the next section). These rat-
ings were used to allocate suitable participants to each of three
groups: Anxious, Depressed and Neither. Individuals with a
score of 4 or more were included in the respective patient
groups (anxious or depressed). Individuals with a score of 3
were not included in the study. Individuals with a score of 2 or 1
on both scales were assigned to the Neither group. In this way
three groups were recruited as follows:
Group 3 (Depressed) consisted of 29 patients (12 males
and 17 females) with a mean age of 41.66 (SD = 10.65).who
were identified by the clinicians as clinically depressed.
Group 4 (Anxious) consisted of 21 patients (12 males and 9
females) with a mean age of 37.29 (SD = 11.68) who were iden-
tified by the clinicians as clinically anxious.
Group 5 (Neither) consisted of 24 patients (12 males and 12
females) with a mean age of 39.38 (SD = 9.09) who were identi-
fied by the clinicians as neither clinically depressed nor clinically
anxious.
Taken together, the full sample consisted of 122 black first
language Xhosa-speaking people (67 women, 55 men). The
mean age of the 65 women was 36.16 (SD = 13.04) and of the
55 males was 34.64 (SD = 11.90). The samples were not ex-
actly matched for gender or age. In practice, there was consid-
erable similarity in the age ranges within all samples except the
student group whose members were, as would be expected,
considerably younger and more homogeneous with respect to
age. In the validation studies of the original scales, no effects of
age were found in outpatient samples on the BDI-II (Beck et al.,
1996) or BHS (Beck & Steer, 1988). There was a low but signif-
icant correlation with age on the BAI (r = -.14) with younger out-
patients reporting more anxiety symptoms than older ones
(Beck & Steer, 1993). Beck et al. (1996) indicate that the BDI-II
can be used from age 13 upwards, Beck and Steer (1988) also
report the use of the BHS from age 13 upwards while Beck &
Steer (1993) recommend the use of the BAI from age 17 up-
wards. In terms of the kinds of analyses being performed and
the kinds of hypotheses being tested, there was no need for
ages to be matched as age is not a confounding factor with re-
spect to any of the conclusions to be drawn.
With respect to gender, there is evidence that, both in pa-
tient and general samples, females tend to report more symp-
toms of depression and anxiety than males on the BAI and
BDI-II (Beck & Steer, 1989; Beck et al., 1996). This reflects the
fact that in epidemiological studies many anxiety disorders as
well as Major Depressive Disorder and Dysthymic Disorder are
more common in females than in males (American Psychiatric
Association, 2000). No gender differences have been reported
for the BHS (Beck & Steer, 1988). In clinical and research set-
tings the scales are used in the same way with respondents of
both genders and therefore there is no need to balance samples
exactly for gender except where gender effects might bias the
kinds of conclusions being drawn. This was not the case in the
present study.
Instruments and Procedure: Through discussion with some
of the practitioners who were to use them, two rating scales
were designed for clinicians to rate their perceptions of the de-
gree of depression and anxiety of each patient. . For the depres-
sion measure, the scale points were based on the diagnostic
categories of the DSM-IV (American Psychiatric Association,
1994). The scale points were defined as follows: 7: "Presence of
severe symptoms of depression as might be found in a severe
Major Depressive Episode," 6: "Presence of marked symptoms
of Depression as might be found in a moderate Major Depres-
sive Episode," 5: "Presence of moderate symptoms of depres-
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sion as in Adjustment Disorder or Dysthymia.,” 4: "Presence of
symptoms of depression as in mild Adjustment Disorder or
Dysthymia,” 3: "Some symptoms but not enough for any clinical
diagnosis,” 2: "Some mild transient symptoms,” 1: "Little or
nothing.” For the anxiety scale the scores were defined as 7:
"Presence of severe symptoms of anxiety as might be found in
Panic Disorder or Post-traumatic Stress Disorder,” 6: "Pres-
ence of marked symptoms of anxiety as might be found in Gen-
eralised Anxiety Disorder or entry into phobic situations,” 5:
"Presence of moderate symptoms of anxiety as in Adjustment
Disorder or Phobia,” 4: "Presence of symptoms of Anxiety as in
mild Adjustment Disorder or Phobia.,” Definitions of scale points
3 to 1 were the same as for the depression rating scale. The re-
liability of these rating scales was examined by having them ad-
ministered twice a few days apart by different evaluators for a
few patients. Unfortunately the numbers were low, but the cor-
relations obtained provided some evidence of their validity:
r(10) = .94 (p < .05) for 10 patients to whom the depression rat-
ing scale was administered twice, and r(8) = .94, (p < .05) for the
8 patients to whom the anxiety rating scale was administered
twice.
Care was taken to ensure that the ratings made by the clini-
cians as a basis for allocating patients into the three groups
were not influenced by patients’ responses to the scales. Only
when the patient has been classified into a group were the
XBDI-II, XBAI and XBHS scales administered. Where possible,
scales were administered by a third party. However, where this
was not practically possible, the clinicians administered the
scales but did not look at the responses or score them. In either
case, the scales were only scored when they had been received
by the second author. This meant that classification into the re-
spective patient group was made only on the basis of the clini-
cians’ ratings which were made blind to patients’ responses to
the Beck scales themselves.
Once included in the study, respondents were required to
read and sign a consent form. They then completed a short bio-
graphical questionnaire which asked for gender, age, occupa-
tion, highest school grade completed, tertiary education (if ap-
plicable), and marital status. For the patient groups, clinicians
were also asked to rate the respondent’s command of English
on a four point scale ranging from "Cannot speak or understand
English at all" to "Has a reasonably good command of the Eng-
lish language. Can speak and understand reasonably well."
This item was not used with members of the student sample and
no analyses using this item are reported here. Participants then
completed the three translated scales, the XBDI, the XBHS,
and the XBAI. A pointing device was available for use with illit-
erate respondents. The purpose of which was to help illiterate
respondents indicate to what extent they were experiencing the
symptom in question. The respondents could move the pointer
along a red line to indicate their response. Two of the clinicians
used the device and indicated that it worked well, although they
did not make extensive use of it. They explained that illiterate re-
spondents had no difficulty selecting the appropriate option for
each item on the basis of hearing them read to them.
Data Analyses
Concurrent validity: Concurrent validity was examined by
means of the what Eysenck (1962) termed the method of nomi-
nated groups. The rationale is simple. If a measure of depres-
sion is valid, people known to be depressed should score mark-
edly higher than either a random sample, a general sample, or
people known not to be depressed. The validation of the origi-
nal Beck inventories took place in clinical research settings in
which large numbers of patients were routinely diagnosed ac-
cording the criteria of the current edition of the American Psy-
chological Association’s Diagnostic and Statistical Manual of
Mental Disorders. For example, in the initial development of the
BAI, the criteria of the DSM-III (American Psychiatric Associa-
tion, 1980) were employed (Beck, Epstein et al., 1988). There
was no access to such a comprehensive research infrastructure
in the present study, but the procedures described above, which
identified the Depressed, Anxious and Neither groups were
deemed to be adequate to ensure sufficient homogeneity with
regard to the relevant clinical features of the different groups.
Two of the samples were not selected in a manner expected
to ensure such homogeneity. Members of the Clinical Pilot
sample could have been expected to include several, perhaps a
majority, of members who were clinically anxious and/or de-
pressed and for this reason, this group was not used in the sta-
tistical analysis of this aspect. The Student sample would have
been expected to include a more limited number of respondents
with clinical symptoms. This meant that the comparisons of par-
ticular relevance in this analysis were, for the XBDI-II and the
XBHS, the comparison between the Depressed group and the
Neither group, and for the XBAI, the comparison between the
Anxious group and the Neither group.
In each case, the comparison between the relevant clinical
group (Depressed or Anxious) and the Student group was also
of interest. The first step was to inspect the means and stan-
dard deviations to see whether their pattern fitted with what
would be expected if each of the translated scales were valid.
The second step was to conduct a one-way analysis of variance
of the data from the three samples of direct relevance in each
case, followed by Tukey’s Honestly Significant Difference
(HSD) test to determine whether differences between means
were significant. In each case, the Shapiro-Wilks W test for nor-
mality indicated that distributions were not normal. Levene’s
Test for Homogeneity of Variances was also applied and vari-
ances were found to be homogeneous for the XBAI data, but not
for the XBDI-II and XBHS data. Since, in each case, the actual
differences between the means of the relevant clinical group
and the means of the two comparison groups were very large,
significance levels were high, and since the analysis of variance
is known to be robust with respect to violation of its assump-
tions, the findings can be regarded as trustworthy. However, as
an additional check, the non-parametric Kruskal-Wallis analysis
of variance was also run. To further clarify the range and distri-
butions of scores, frequency histograms were drawn for the De-
pressed, Anxious, Neither and Student groups.
Convergent and discriminant validity: Convergent validity
was examined by examining the Pearson product-moment cor-
relations between clinicians’ ratings and the relevant scale
scores. In one analysis, correlations between clinicians’ ratings
of depression and patient scores on the XBDI-II were obtained.
In a second, correlations between clinicians’ ratings of anxiety
and patient scores on the XBAI were obtained. Discriminant va-
lidity was investigated by calculating Pearson product-moment
correlations between each of the three translated scales.
Results and Discussion
Table 1 shows the means and standard deviations of the
scores of all five groups on each of the three scales.
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Concurrent validity of the BDI-II
For the XBDI-II, inspection of the means in Table 1 reveals a
pattern which accords with what would be predicted if the scale
were a valid measure of depression. The mean for the de-
pressed group was high (in the range indicating severe depres-
sion). This is consistent with the fact that these participants
were identified as depressed by the clinicians and some of them
were in a psychiatric hospital which caters for patients with dis-
abling levels of symptomatology. The mean for the Clinical Pilot
group was at the top of the range usually taken to indicate mild
depression. This group has the largest standard deviation which
suggests it contained some severely depressed members as
well as some who were not depressed at all. This pattern is con-
sistent with the manner in which this sample was obtained. The
mean for the Anxious group was at the top of the range for mini-
mal depression. This suggests that some members of this
group had symptoms of clinical depression. This would be ex-
pected given that clinical anxiety and depression, though differ-
ent syndromes, are often comorbid. The Student and Neither
groups both had means in the normal range, as would have
been predicted.
The means reported in Table 1 also accord with means re-
ported in the validation studies. Beck et al. (1996) reported a
mean of 12.56 (SD = 9.93) for college students. This mean,
somewhat higher than that reported here, could simply be a re-
flection of the fact that our students were asked to volunteer and
report later while the BDI-II was administered to students in the
Beck et al. study during a regular class. The procedure em-
ployed in the present study could have had the effect of reduc-
ing the number of depressed students who participated. Beck
et al. reported a mean of 26.57 (SD = 12.15) for outpatients with
mood disorders. The fact that mean for the Depressed group in
the present study was somewhat higher could also reflect the
sampling procedure. Clinicians did not conduct a comprehen-
sive diagnostic screening and may have been cautious about
rating patients as clinically depressed unless they were very
symptomatic. Beck et al. reported a mean of 19.38 (SD = 11.46)
for outpatients with anxiety disorders. The fact that the mean in
the present study was lower may also be a consequence of the
sampling procedure. Although they were not specifically asked
to do so they reported that they tried to find patients who were
clearly anxious or depressed as they believed that this is what
was wanted for these clinical groups. In two South African stud-
ies using the BDI-II, the mean depression score of a lower
socio-economic community was found to be 11.6 (SD = 8.3)
(Pillay & Sargent, 1999) and a mean depression score of 13.55
(SD = 8.21) was found in a sample of 100 tuberculosis patients
(Westaway & Wolmarans, 1992).
Frequency distributions of the XBDI-II scores for the De-
pressed, Neither and Student groups are shown in Figure 1.
The prediction was that the mean of the depressed group would
be significantly greater than that of the other two groups. Almost
all members of the Depressed group had scores in the clinical
range (Beck et al., 1996, provide guidelines of 14-19 for Mild,
20-28 for Moderate and over 28 for Severe). The majority of the
Neither group were well within the normal range, and there was
a small subgroup in the Student sample who were in the clini-
cally depressed range. The means and standard deviations are
consistent with what would be expected, given the way the sam-
ples were obtained. Application of analysis of variance yielded a
test statistic [F(2,76) = 94.06] significant well beyond the .001
level. The distribution departed from normal (W = .88, p < .05)
and there were significant differences between the samples
with respect to variability [Levene’s Test: F(2, 76) = 8.46, p <
.001]. However, application of the Kruskal-Wallis analysis of
variance confirmed that there was a significant effect [H(2,
N=79) = 51.07; p <.001). Application of Tukey’s (HSD) showed
that the mean of the Depressed group was significantly higher
than that of both the Neither group (p <.001) and the Student
group (p <.001). There was no significant difference between
the means of the Neither and Student groups (p = .96). These
findings therefore indicate that, in accordance with prediction,
the XBDI-II scores of the Depressed group were significantly
higher than those of the Neither and Student groups.
Concurrent validity of the XBHS
For the XBHS, inspection of the means in Table 1 reveals a
pattern which accords with what would be predicted if the scale
is a valid measure of hopelessness. Beck and Steer (1988) re-
ported means of 10.1 and 10.4 for samples of patients diag-
nosed with Major Depressive Disorder and 9.03 for patients with
dysthymic disorder. The mean of 9.86 for the depressed group
in the present study is therefore well in line with that found in the
validation studies for the original BHS. It is a relatively high
value in terms of being of clinical significance, since 9 is re-
garded as the cut off for alerting clinicians to check for and mon-
itor suicide risk (Beck et al., 1989; Beck & Steer, 1988). The re-
maining means are relatively low and in line with means
reported by Beck & Steer (1988) for various clinical and
non-clinical samples. In a South African study of a community
sample drawn from a lower socio-economic group, Pillay and
Sargent, (1999) obtained a mean BHS score of 3.9 (SD = 3.5).
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XBDI-II XBHS XBAI
Group N M SD M SD M SD
Pilot 22 19.23 13.94 4.23 4.12 19.27 12.56
Student 26 7.92 9.72 1.23 2.53 7.58 9.02
Depressed 29 31.21 6.10 9.86 4.10 14.90 6.14
Anxious 21 13.05 9.45 3.81 3.66 28.71 8.88
Neither 24 7.33 5.57 1.92 1.64 6.96 6.55
Full sample 122 16.26 13.05 4.40 4.64 14.94 11.61
Table 1. Means and Standard Deviations of the XBDI-II, XBHS and XBDI
Frequency distributions of the XBHS scores for the De-
pressed, Neither and Student groups are shown in Figure 2.
The prediction was that the mean of the Depressed group would
be significantly greater than that of the other two groups. The
majority of the Depressed group displayed clinically significant
levels of hopelessness (9) although several did not. This ac-
cords with the fact that although pessimism and hopelessness
are one possible component of depression, not all clinically de-
pressed patients are hopeless. The Neither group displayed
very low levels of hopelessness, while there were only a very
few students whose scores were in the range that would be
grounds for clinical concern. In each case this fits well with what
would be expected given the inclusion criteria used for each of
these samples. Application of analysis of variance yielded a test
statistic [F(2,76) = 69.6] significant well beyond the .001 level.
The distribution departed from normal (W = .83, p < .05) and
there were significant differences between the samples with re-
spect to variability (Levene’s Test: F(2, 76) = 3.57, p < .05) How-
ever, application of the Kruskal-Wallis analysis of variance con-
firmed that there was a significant effect [H(2, N=79) = 42.07; p
<.001]. Application of Tukey’s (HSD) test showed that the mean
of the Depressed group was significantly higher than that of
both the Neither group (p < .001) and the Student group (p
<.001). There was no significant difference between the means
of the Neither and Student groups (p = .71). These findings
therefore indicate that, in accordance with prediction, the XBHS
scores of the Depressed group were significantly higher than
those of the Neither and Student groups.
Concurrent validity of the XBAI
For the XBAI, too, inspection of the means in Table 1 re-
veals a pattern which accords with what would be predicted if
the scale is a valid measure of anxiety. The mean for the Anx-
ious group was high (in the range indicating severe anxiety).
This accords with the fact that these participants were identified
as anxious by the clinicians and some of them were in a psychi-
atric hospital which caters for patients with severe and disabling
symptoms. The mean for the Clinical Pilot group was in the
range for moderate clinical anxiety. The large standard devia-
tion suggests that this sample included some severely anxious
members as well as some with little or no anxiety. The mean for
the Depressed group was at the top of the range for mild anxiety
(8-15). The relatively low standard deviation suggests that most
members of this group had some degree of anxiety too. The
mean of the Student group was at the bottom of the range for
mild anxiety, while the mean of the Neither group was within the
range of what is considered normal.
Frequency distributions of the XBAI scores for the Anxious,
Neither and Student groups are shown in Figure 3. The predic-
tion was that the mean of the anxious group would be signifi-
cantly greater than that of the other two groups. All members of
the Anxious group had scores in the clinical range and over half
had severe levels of anxiety (Beck & Steer, 1993 provide guide-
lines of 8-15 for Mild, 16-25 for Moderate and over 26 for Se-
vere). Several of the members of the Neither group reported
clinical levels of anxiety though none were in the severe range.
This could reflect that the fact anxiety symptoms are often more
situational and occur in brief episodes as compared to de-
pressed mood which is often long-lasting and chronic. Clini-
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Figure 1. Distribution of XBDI-II Scores for the Depressed, Student and Neither Groups
cians doing a relatively brief assessment may have failed to pick
up anxiety symptoms in patients who were not experiencing sig-
nificant anxiety around the time of assessment itself. This is a
phenomenon commonly observed clinically. The majority of the
Student group reported little or no anxiety, but there were sev-
eral who reported clinical levels of anxiety in the mild to moder-
ate range, a pattern which accords with what might be expected
in a volunteer sample. Application of analysis of variance
yielded a test statistic [F(2, 68) = 50.28] significant well beyond
the .001 level. The distribution departed from normal (W = .90, p
< .05) but differences between the samples with respect to vari-
ability were not significant [Levene’s Test: (F(2, 68) = 2.84, p >
.05]. Application of the Kruskal-Wallis analysis of variance con-
firmed that there was a significant effect [H(2, N=71) = 37.66; p
<.001). Application of Tukey’s (HSD) test showed that the mean
of the Anxious group was significantly higher than that of either
the Neither group (p <.001) or the Student group (p <.001).
There was no significant difference between the means of the
Neither and Student groups (p = .96). These findings therefore
indicate that, in accordance with prediction, the XBAI scores of
the Anxious group were significantly higher than those of the
Neither and Student groups.
Convergent validity: Correlations with the rating scales
The use of rating scales in the assignment of participants to
the respective patient groups provided an opportunity for us to
test the convergent validity of the BDI-II and BAI. Ratings on the
depression rating scale were independent clinical ratings of the
levels of depression and ratings on the anxiety rating scale were
independent clinical ratings of levels of anxiety. Unfortunately,
due a misunderstanding, some clinicians had not completed rat-
ing scales in cases where they did not think they applied (e.g.,
when a patient was classified as depressed, no anxiety rating
scale was completed for that patient). However, overall, there
were 53 patients for whom we had depression ratings and 45 for
whom we had anxiety ratings. If the BDI-II and BAI are valid
measures of depression and anxiety respectively, it would be
expected that there would be a substantial correlation with the
respective rating scales. This proved to be the case. A correla-
tion of .91 was obtained between BDI-II scores and depression
rating scale scores and a correlation of .88 was obtained be-
tween the BAI scores and the anxiety rating scale scores.
Inter-correlations between the translated scales
The next step was to calculate Pearson product-moment
correlations between the scores on the three translated invento-
ries. For this analysis we used data from the full sample of 122
respondents. The relationships between the three Beck scales
have been established and confirmed numerous times in a se-
ries of different studies (Beck, Epstein et al., 1988; Beck et al.,
1996; Beck Steer, & Garbin, 1988). High to moderate correla-
tions are typically found between measures of anxiety and de-
pression. This is in part because of co-morbidity, since many
patients present with both anxiety and depression. However, it
is also because many of the features traditionally associated
with anxiety and depression overlap and many scales for the
measurement of anxiety and depression have items with similar
or overlapping content Beck and colleagues have argued that
although they can occur together, anxiety and depression are
phenomenologically different. Anxiety, they argue, is experi-
enced in response to appraisal of threat of danger, whether this
concerns physical safety, or damage to self esteem, social posi-
tion or financial security for oneself or someone else one de-
pends on or is close to. Depression is experienced in response
to actual loss, hence the characteristic states of pessimism,
sadness, hopelessness, loss of self-worth and low motivation
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Figure 2. Distribution of XBHS Scores For the Depressed, Student and Neither Groups
(Beck, Brown, Steer, Eidelson, & Riskind, 1987). This approach
lies behind the fact that in the DSM diagnostic system anxiety
disorders are categorized separately from affective disorders.
Although the ICD-10 (The ICD-10 classification of mental and
behavioural disorders, 1992) includes a category called "Mixed
anxiety and depressive disorder" (F41.2) it is a residual cate-
gory for presentations with mild symptoms of both anxiety and
depression and there are so many qualifiers in the diagnostic
description that it is not likely to be used except rarely. In the
DSM-IV, the diagnostic category of "mixed anxiety-depressive
disorder" is also not for normal clinical use. It is listed in an ap-
pendix of diagnostic categories which merit further study and re-
search. In developing the BAI and BDI, Beck sought to eliminate
the overlap between the content of items to get as close as pos-
sible to "pure" measures of anxiety and depression. Beck and
Steer (1993) obtained a correlation of .48 between the BAI and
BDI-IA from a mixed clinical sample. This was considerably
lower than correlations obtained between measures of depres-
sion and earlier anxiety measures. However, a higher correla-
tion of .6 was obtained between the BDI-II and the BAI (Beck et
al., 1996). For the purposes of the present study the correlation
between the XBDI-II and the XBAI served as means to assess
discriminant validity. A correlation of .49 (p <.05) was obtained
which is close to the correlation obtained in the validation study
of the BDI-IA and lower than that reported for the BDI-II. This
suggests that the XBAI and XBDI-II are able to discriminate
anxiety from depression well.
Hopelessness and depression are related constructs since
a significant percentage of depressed people experience pessi-
mism and hopelessness. Furthermore, the association of sui-
cide with depression is largely mediated by hopelessness.
Consequently a significant positive correlation between the
XBDI-II and the XBHS was to be expected. Beck and Steer
(1989) reported a correlation of .68 between the BDI-II and the
BHS. The same value of .68 (p <.05) was obtained in the pres-
ent study. Beck and Steer (1988) comment that typical correla-
tions reported in the international literature between the BDI and
the BHS may be inflated by the fact that item 2 of the BDI-II also
taps pessimism. They therefore recommend that the contribu-
tion of item 2 be subtracted from the BDI scores before correlat-
ing them with the BHS. In overseas studies, correlations of total
BDI-II scores (minus the Pessimism score) with total scores of
the BHS range between .44 and .74. Where, the Pessimism
item is not subtracted, the correlation coefficient may be as
much as two points higher (Beck et al., 1975; Beck & Steer,
1988; Nekanda-Trepka, Bishop, & Blackburn, 1983). However,
when this correction was made with the present data, the same
value of .68 was obtained. The fact that we obtained the same
correlation as in the validation study of the original English ver-
sions is encouraging since it provides evidence not only for con-
vergent validity but also for the construct validity of the trans-
lated scales since it is consistent with the conclusion that the
translated scales are functioning in the same way as the origi-
nals.
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Figure 3. Distribution of XBAI Scores For the Anxious, Student and Neither Groups
Beck et al. (1974) correlated the scores of the BDI-IA Pessi-
mism item with total scores of the BHS and obtained a correla-
tion of r = .63. They also reported the range of correlation for the
BDI-IA and the BHS to be .56 to .64. When correlating scores of
the XBDI-II Pessimism item with total scores of the XBHS in the
present study, a correlation of .49 was obtained. Although lower
than that reported by Beck et al., it is in line with test-item corre-
lations obtained within the XBHS which range between .38 and
.61 (Steele & Edwards, 2008 b) as well as those reported for the
BHS itself which range between .75 and a low of .06 across sev-
eral samples (Beck & Steer, 1988). The authors could find no
reports of correlations between the BDI-II Pessimism item and
BHS scores in the literature.
Finally, as a test of discriminant validity, little or no relation-
ship would be expected between scores on the XBAI and the
XBHS. This is because there is no phenomenological relation-
ship between anxiety and hopelessness. Beck and Steer,
(1989a) obtained a correlation of .15 between the BHS and the
BAI. We obtained a rather higher value of .21 (p <.05). Although
the relationship is statistically significant it is effectively very
weak and quite in line with the low level of covariation that would
be expected.
It is interesting to compare the intercorrelations obtained
here with those obtained by Pillay and Sargent (1999) with a
lower socioeconomic community sample from KwaZulu-Natal.
They used the original 1961 version of the BDI, as well as the
BHS and the BAI. They did not discuss how they dealt with
translation at all, even though at least 10% of their sample had
not been to secondary school. All intercorrelations were very
high (BDI with BHS = .85; BDI with BAI = .80; BAI with BHS =
.90). Although they suggest that their findings suggest that all
the inventories are tapping a broad factor of "general psycho-
logical distress", another explanation that needs to be consid-
ered is that the manner in which the scales were administered
resulted in strong response sets. The results of the present
study show that when carefully translated and administered, the
same levels of convergent and discriminant validity can be dem-
onstrated as was found in the original validation studies over-
seas.
Conclusions
The analyses presented in this paper provide evidence that
the XBDI-II, XBHS, and XBAI will function clinically in much the
same way as their English counterparts. Nominated groups of
Depressed, Anxious and Neither depressed nor anxious pa-
tients responded to the scales in ways which accorded with pre-
dictions. This provides evidence that the scales provide valid
measures of Depression, Anxiety and Hopelessness. The re-
sults of the research reveal excellent psychometric properties
for the three translated inventories. The internal consistencies
found for the three inventories are all high and very much com-
parable with those found in the international literature (Steele &
Edwards, 2008b). The analyses reported here provide evidence
that the translated inventories exhibit suitable levels of concur-
rent, convergent, and discriminant validity. In turn, the finding
that the translated scales have such excellent psychometric
properties provides evidence for the quality of the translations. If
constructs from the English could not be adequately rendered in
Xhosa, or if the translations conveyed different meanings to the
original items, this would be likely to have a negative effect on
the results of the analyses reported here and by Steele and Ed-
wards (2008 b).
The advantage of translating scales developed overseas
which have considerable research backing is that, if the transla-
tion process can be negotiated successfully, a considerable
body of existing research can be drawn on in interpreting the
translated scales. The development of the XBDI-II, XBHS, and
XBAI was undertaken working closely with clinicians in practice
and the validation process involved clinical pilot testing in
Grahamstown, East London and Port Elizabeth and in private
practice settings and a psychiatric hospital. It can therefore be
expected that they are suitable for use in clinical settings, for
routine assessment and monitoring of symptoms, and in re-
search where valid measures of these constructs are needed
for Xhosa-speaking participants.
One setting in which the XBDI-II and XBAI could serve as
valuable screening instruments is in Primary Health Care clin-
ics. In the District Health System patients with psychological
problems are supposed to be referred from the Primary to the
Secondary Health Care levels. The burden of assessment and
referral often falls to nurses who must process large numbers of
patients and the lack of time and the limitations of training of
staff mean that clinically significant depression and anxiety are
easily missed. Even medical doctors often fail to pick up psy-
chological symptoms in patients. Carey, Stein, Zungu-Dirwayi,
& Seedat (2003) interviewed Xhosa-speaking individuals at-
tending a primary health care clinic in Khayelitsha, Cape Town.
They found that the majority of patients had some exposure to
the kinds of violence that could result in posttraumatic stress
disorder (PTSD), 44% had suffered from PTSD at some time in
their lives and 20% currently met the criteria for PTSD (mean
duration was nearly five years). In no case did the medical re-
cords reflect a recognition of the significance of the trauma, a di-
agnosis of PTSD or any indication that any medication had
been prescribed to address anxiety symptoms and health pro-
fessionals seemed to have a limited understanding of the rela-
tionship between violence and mental disorders. Marais, de
Villiers, Möller and Stein (1999) also drew attention to the diffi-
culties of recognizing psychological problems in practice set-
tings that are largely medically oriented. They interviewed black
and white women visiting general practitioners in several South
African cities. Over 20% of interviewees had been victims of do-
mestic violence (although in half the cases it was not recent)
and symptoms of anxiety and depression were more common
among these women than in a control group of women who had
not been victimized. Few had mentioned the violence to their
doctors and the doctors themselves were surprised at the fre-
quency with which domestic violence lay behind apparently un-
explained medical symptoms.
If applied in primary care settings, practitioners should be
alert to the fact that these instruments do not, by themselves,
provide a firm diagnosis. Rather they serve as tools that draw
attention to the existence of significant mental health problems.
The XBHS is less suited to such routine use, because all 20 of
its items tap the same construct. However, it could be given
when patients have elevations on the pessimism and /or suicide
items of the XBDI-II as a means of checking degree of suicide
risk and therefore the urgency of referral to a psychological or
psychiatric service.
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